TG Therapeutics, Inc. (TGTX)
40.95
+0.79
(+1.97%)
USD |
NASDAQ |
Jun 08, 16:00
42.00
+1.05
(+2.56%)
After-Hours: 07:53
TG Therapeutics Total Assets (Quarterly) : 1.529B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.397B |
| MAIA Biotechnology, Inc. | 35.32M |
| Vericel Corp. | 485.63M |
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| United Therapeutics Corp. | 6.714B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 945.71M |
| Shareholders Equity (Quarterly) | 583.13M |
| Debt to Equity Ratio | 1.292 |
| Current Ratio | 5.809 |
| Net Debt Paydown Yield | -1.97% |